Kairos Discovery is a biotechnology business that is exploring novel targeted cancer medicines.
Kairos Discovery has raised $1.3M in total funding. The most recent round was Seed. The last funding was announced in May 2023.
Kairos Discovery's investors include Bpifrance, Health Angels Rhône-Alpes, 33 California.
Kairos Discovery is headquartered in Lyon, France.
Kairos Discovery is a biotechnology business that is exploring novel targeted cancer medicines.
Kairos Discovery is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kairos Discovery — Funding & Investors." VCBacked, May 2, 2023, https://www.vcbacked.co/company/kairos-discovery. Accessed October 1, 2026.
VCBacked. (2023). Kairos Discovery — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/kairos-discovery
{{cite web |title=Kairos Discovery — Funding & Investors |url=https://www.vcbacked.co/company/kairos-discovery |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated